The M&A Hunter
Tracking biotech acquisition targets before big pharma strikes. Featuring acquisition targets with detailed analysis M&A probability signals and catalysts Valuation insight and deal timing estimates Big pharma strategy patterns "NOT Pro Advice"
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 337 | Founded | 7 months ago | Last Issue | 3 days ago |
| Active | |||||
Read this Newsletter
maandhunter.substack.comLatest Issues
Week in Review
5/22/2026
S1 — Market Commentary
BDTX Black Diamond Therapeutics ASCO
Black Diamond Therapeutics (BDTX) reported updated Phase 2 results for silevertinib in treatment-naïve non-small cell lung cancer patients with EGFR non-classical mutations.
Share
Silevertinib is a fourth-generation, covalent, CNS-penetra...
CLYM Climb Bio Inc EHA 2026
Climb Bio (CLYM), budoprutug (TNT119), a low-fucosylated anti-CD19 monoclonal antibody, in adults with primary immune thrombocytopenia (ITP): initial Phase 1b study results
EHA 2026 – Poster Presentation (EHA-3069 / PS2440)
Climb Bio repo...
IOVA Iovance Biotherapeutics ASCO
Long-term survivorship rates among previously treated advanced melanoma patients achieving objective response with lifileucel (Iovance Biotherapeutics)
This ASCO update focused on long-term outcomes from the Phase 2 C-144-01 study of lifil...
CRBP Corbus Pharmaceuticals ASCO
5/22/2026
One of the more interesting ADC stories developing quietly at ASCO was CRB-701.
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for The M&A Hunter.
| Subscribers | Engagement | 82 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Tracking biotech & Banking acquisition targets Featuring acquisition targets with detailed analysis M&A probability signals and catalysts Valuation insight and deal timing estimates Big pharma strategy patterns "NOT Pro Advice"
Frequently Asked Questions
How can I access the email archive for The M&A Hunter?
You can find recent issues that have been published by The M&A Hunter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does The M&A Hunter have?
To see how many people subscribe to The M&A Hunter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in The M&A Hunter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch The M&A Hunter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like The M&A Hunter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The M&A Hunter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to The M&A Hunter?
Scroll up to where it says Related Newsletters to see other publications like The M&A Hunter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact The M&A Hunter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.